Management of borderline ovarian tumours.
Gershenson DM.
Best Pract Res Clin Obstet Gynaecol. 2017 May;41:49-59. doi: 10.1016/j.bpobgyn.2016.09.012. Epub 2016 Oct 3.
Ovarian cancer development and metastasis.
Lengyel E.
Am J Pathol. 2010 Sep;177(3):1053-64. doi: 10.2353/ajpath.2010.100105. Epub 2010 Jul 22.
Needleoscopic Conservative Staging of Borderline Ovarian Tumor.
Gueli Alletti S, Rossitto C, Perrone E, Cianci S, De Blasis I, Fagotti A, Scambia G.
J Minim Invasive Gynecol. 2017 May-Jun;24(4):529-530. doi: 10.1016/j.jmig.2016.10.009. Epub 2016 Oct 27.
Endometriosis-associated cancer.
Guidozzi F.
Climacteric. 2021 Dec;24(6):587-592. doi: 10.1080/13697137.2021.1948994. Epub 2021 Jul 16.
Advancements in Low-Grade Serous Carcinoma of the Ovary and Peritoneum.
Grisham RN, Chui MH.
Curr Oncol Rep. 2022 Nov;24(11):1549-1555. doi: 10.1007/s11912-022-01315-y. Epub 2022 Aug 13.
Management of borderline tumors of the ovary: state of the art.
Tropé C, Kaern J.
Semin Oncol. 1998 Jun;25(3):372-80.
Borderline ovarian tumours.
Tropé CG, Kaern J, Davidson B.
Best Pract Res Clin Obstet Gynaecol. 2012 Jun;26(3):325-36. doi: 10.1016/j.bpobgyn.2011.12.006. Epub 2012 Feb 7.
Genetic diagnosis of pseudomyxoma peritonei originating from mucinous borderline tumor inside an ovarian teratoma.
Taguchi A, Rokutan H, Oda K, Tanikawa M, Tanimoto S, Sone K, Mori M, Tsuruga T, Kohsaka S, Tatsuno K, Shinozaki-Ushiku A, Miyagawa K, Mano H, Aburatani H, Ushiku T, Osuga Y.
BMC Med Genomics. 2022 Mar 7;15(1):51. doi: 10.1186/s12920-022-01188-x.
A diagnostic challenge of primary serous borderline tumor involving the peritoneum: A case report.
Masoud R, Hamed H, Abdelrazek HM, Emara M, Abdelsalam RA.
Int J Surg Case Rep. 2025 Aug;133:111527. doi: 10.1016/j.ijscr.2025.111527. Epub 2025 Jun 16.
Management of borderline ovarian neoplasms.
Cadron I, Leunen K, Van Gorp T, Amant F, Neven P, Vergote I.
J Clin Oncol. 2007 Jul 10;25(20):2928-37. doi: 10.1200/JCO.2007.10.8076.
